News and Reports

Globe
  • Neurelis Enters $208 Million Agreement to Monetize Intravail Royalties

    14 November 2024
    Download
  • Numab Therapeutics Announces Initiation of Phase 1 Clinical Study of NM32 Program in Patients with Solid Tumors

    30 October 2024
    Download
  • Molecular Partners Announces Pricing of $20 Million Underwritten Offering

    25 October 2024
    Download
  • OneSource, the Group’s Spec Pharm CDMO, receives equity commitments of INR 8,010 mn (USD 95 mn) from marquee investors at a pre-money equity valuation of USD 1.65 bn

    16 October 2024
    Download
  • Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care

    9 October 2024
    Download
  • C-Ray Therapeutics Announced Approval of the First Radiation Safety License for Its Chengdu Facility in China

    27 September 2024
    Download
  • SWIXX Signs Agreement With Krystal Biotech For VYJUVEK® Gene Therapy

    25 September 2024
    Download
  • "Leading Mobile Healthcare Company" FANGZHOU JIANKE (06086) to Form Strategic Partnership with Tencent to jointly promote the upgrade of internet healthcare intelligence.

    20 September 2024
    Download
  • Upstream Bio Announces Oral Presentation of New Data from a Phase 1b Multiple Ascending Dose Trial of Verekitug (UPB-101) in Adults with Asthma at the European Respiratory Society Congress

    9 September 2024
    Download
  • ArriVent Announces Positive Proof-Of-Concept Global Phase 1b Interim Data for Firmonertinib Monotherapy In First-Line EGFR PACC Mutant Non-Small Cell Lung Cancer At The 2024 World Conference On Lung Cancer

    9 September 2024
    Download
  • SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers

    8 August 2024
    Download
  • Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-01, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-01, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Pso

    29 July 2024
    Download
  • Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer

    24 July 2024
    Download
  • Genalyte - FDA Clears Silicon Chip Based Blood Test

    22 July 2024
    Download
  • Johnson & Johnson strengthens pipeline to lead in atopic dermatitis with acquisition of Yellow Jersey Therapeutics

    11 July 2024
    Download
  • SWIXX BioPharma formally closes the deal with Biopas, expanding to Latin America

    4 July 2024
    Download
  • Monte Rosa Therapeutics Provides Development Progress Updates on MRT-2359 and MRT-6160

    27 June 2024
    Download
  • Transaktion HBM-Portfoliounternehmen Yellow Jersey geht an Johnson & Johnson

    28 May 2024
    Download
  • Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-specific Antibody for the Treatment of Atopic Dermatitis

    28 May 2024
    Download
  • Swixx BioPharma Expands to Latin America Through a Strategic Acquisition and Combination with Biopas

    22 May 2024
    Download
  • Bluejay Therapeutics Secures $182 Million in Series C Financing to Propel Clinical Pipeline

    9 May 2024
    Download
  • Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis

    2 May 2024
    Download
  • NiKang Therapeutics Doses First Patient in a Phase 1/1b Study of NKT3447, an Oral, Selective Inhibitor of CDK2 Which Reduces Cyclin E Expression

    15 April 2024
    Download
  • Upstream Bio Announces Appointment of Rand Sutherland as CEO and Additions to Leadership Team

    2 April 2024
    Download
  • eGenesis Announces World’s First Successful Transplant of Genetically Engineered Porcine Kidney in a Living Patient

    21 March 2024
    Download